Stocks and Investing Stocks and Investing
Wed, September 27, 2023
Tue, September 26, 2023

Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $82 on, Sep 26th, 2023


Published on 2024-10-28 06:35:06 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $82 on, Sep 26th, 2023.

Douglas has made no other calls on APLS in the last 4 months.



There are 11 other peers that have a rating on APLS. Out of the 11 peers that are also analyzing APLS, 3 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $43 on, Friday, September 8th, 2023
  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $29 on, Wednesday, August 23rd, 2023
  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $60 on, Thursday, August 3rd, 2023


These are the ratings of the 8 analyists that currently disagree with Douglas


  • Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $64 on, Friday, September 15th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $60 on, Wednesday, August 30th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Wednesday, August 30th, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Tuesday, August 29th, 2023
  • Justin Kim of "Oppenheimer" Reiterated at Buy on, Wednesday, August 23rd, 2023
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $64 on, Wednesday, August 23rd, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $89 on, Tuesday, August 1st, 2023

Contributing Sources